Search
![Learning about molecular glues from the CEO of Orionis Biosciences following a recent Genentech deal](https://static.wixstatic.com/media/08e71b_26a2e74675a44cb3a602023232018058~mv2.png/v1/fill/w_326,h_245,fp_0.50_0.50,q_95,enc_auto/08e71b_26a2e74675a44cb3a602023232018058~mv2.webp)
Sep 25, 2023
Learning about molecular glues from the CEO of Orionis Biosciences following a recent Genentech deal
Niko Kley explains the concept of molecular glues, and how Orionis is also trying to design cytokines that are selectively activated.